www.psychoreanimatology.

org

. .

 616.895.4:615
56.14-324
95
. . .
, 2009. - 77 .

;
,

.
,
.
, ,
.
,
.

: . . ,
: , ,

. ., 2009

..5
6
.....8
I. 9
.........................9
10

11
,
.12

(
?)17

21
II. .....23
,
.23
...25

III.

()

...33
: ( ,

?)33
: 38
: ......40
: +
()..43
: ...51
1. ....51
...51
.....53
....54
...56
.56
3

 57
.58
2.
..58
- ...59
.60
....60
..61
().....62
( ).......63
...65
.......68

,
,
.
, , ,

,

.

.

. ,

,
.

.
,
.

.

, .
,

.
,
,
?

,
. ,
, ,

, .
, ,

-
-
-



-

-




3
4

, ,
, . ,
:
( ,
),
() ,
. ,
,
. ,
,
, .

,
, , ,

. ,
.
(, , )
, ..
.

, ,

.
.
,
(, , ),


.

-,
( ) ()
.

,
.

 ,

I



, ,
. , ,
, ,

,
. ,
.
,

, ,


, 3060%
, ,
(
) (. . , 1992; . .
2006; . . , 2006). ,


, . 6075%

(. Ballas, 2002), 510%
,
, (. . Thase, 1987; .
. Nierenberg, 1990).
(, )
4% (. . ,
2006), 1945 2000
20 45%
(Cross-national, 1999). ,
,

. ,

(J. M. Russell,
2004). (
)
, ,
. , ,
,
.

,
. ,
.

- ,
-
.
,
, ,
.

,
,
.


. , ,

, .

. , ,

,

.

(. .
, 1975; . . , 2004) :

10


,
()
() .

,


.


,
. 70- (

)

. 70-
.

,
, ,
.
( ):
, , ,
.
,
. ,
(
) ,
( ,
). 1986
,

, ,
.
(. .
, 1995; . , 1999; . . , 2005; . . Trivedi,
2003), ,

11

 ( 34 )
,
(
50%).
, ,
, ,

.

(. . , 1992).
, ,
? , , ,
,

,
.
,


,
(. . , 1988).
:
1. (
).
2. ,
.
3. .
4.

.
.
, ,
.
( )
3%.
( 16%),
,
.

12

. ,
,
,
( 13%). 42%
,

.

70-80- (
).

(. . , 1989).
,
(

).

,
-
( -
).

(. . , 1975):
1) ,
( ,
);
2)
,

;
3) (
).

.
,
.
(. . , 2004; . .
, 2007; . . , 2008)
:
- () .
,

13

, (
)

.
, ,
( ,
), ( )
. ,

. . . (2009) ,
,

.
,
. ,
.

( ).
,
,

,
( ,
, )

,
. ,
.

,
,
.

,

. ,

14

 (200 /)
, , 4- .
- . , ,
(,
5060% ).
- (
).

(,
,

). ,
,
,

.
,
(. . , 2008). ,

,


.

. . (2002),
:
I ,

- ,
.
1018% .

. 1517% .
-
, : ,
2+-, , ,
.
- ,
. 1996 .,
50% .

15

II ,

- , ,
, ,
.
- : , ,
, , ,
, , ,
.
- .
III ,

- :
, ,
,
,
.
-

.
- : ,
, .
IV
,

- .
- , .
, . .
(1995), :
- ;
- ;
- ,
(, , );
-
(, , );
- ;
- .
. . (1998), ,

16

,
,
, .
(M. E. Thase A. J. Rush, 1997)

.

(
3540% ).

(
3550% ).


( 5272%).

(
40% ).

( 5084%),
.

,

,
(. . , 2008).


(
?)
()
.
: .
, ,

. ,

( ?)

17

, :
, ,
,
.

10

(. . , 2006).
,
,
, ,
.
(
) :

.
. . (1989)

:
1.
,
( )
.
2. ,
,
.
3.
,
.

.
4.
( ),
.
. . (2006),
2030%
(
). :

,

18

 ,
. , 70 %
80 % ,
(. . , 2006).
, 60 %
,
(. . , 2005).
, ,
,
, .
: (
).
, ,

( -
).

,
.
,
,
, ,

.
,
(
),
.
: (
).
,

, ,

, .

(
).
.
, (

19

 )
(. . , 2005). ,
( ),
.

)
,
. ,

.

,
(. . , 1990). 90%
, , ,
, .
,

.

( ,
).
:
.

. , 5080%
, 47 %
(. . , 2006).

.
:
.

( ,
, ),
( , , ,
, ). , 95%

20


.
:
( , ,
). ,

,
.

, , .
,
(,
, , )
.


, ,

.

. . . (2005),

.

,

, : , , , .
, ,
.

( ),
- ,
, .
,
:

21

. . (1989)
:
1.
.
2. .
3. .
4.
.
5.
.
6.
.
. . (1992)
:
.
,
.

,
.

,
, .
.
,
, ,

.
. . (2005),
: , .
,
?


. ,

22

. ( )
(
)
, ,
.
.
1.

2-

-
-
-
,

-
-
-

II

,

,

.

23

 . , 70-
35 ,
15
(
50 ).
, , ,
, ,

. ,

,
.
.
,
(
, ,
). , :
)
;
)

;
)
.

3
( . . , 1995):
1)
,
,
.

( 612 ).
2)

(
)
,


.
59 , 34 .
3)
() ,
.
,

24

 . ,
5 ,
.
.
,
,
.
, ,

.
:
, ,
.
,
, , ,
(
) ,
,
. ,

,
(),
(. . , 1999).
, ,

.

,
, ,
(
2 3).
,
, ,
.


, , .
, ,

25

, , ,
,
, .

, ,
,

(, , ,
)
( )
().
,

. ,

;
, ,
(1), -1, -2 (5-2)
.
1,
:
(, . MAOI)
(, . TCA)
(, . HCA)

(, . SSRI)

(C, . NARI)

(C, . SNRI)

(, . SDRI)

(, .
NaSSA)

, .

26


(, . SSA)

:

(, . MAOI)

.
(),
(),
, ,
, .


() .

- (, , , ) -B
() ,
,
, ,
.
- -B

,
.
(, . TCA)
, ,

,


. ,

() .
.
,
,
(tertiary amine tricyclics),

27

, (secondary amine
tricyclics).

, . ,
,
.
, ,
,
(-,
, -),

, .
,
(), (, ),
(), , ().
(, ,
), ,
,
, , -
,
(
,
).

.
, (
),

, ,
,
.
:
1. ();
2. ();
3. ();
4.
,
(),

28

5.
6.

(), (), ;
, ();
(,
);
();
().

(, . HCA)

,
( )
.
, .
().
, , ()
(), 4 (
) ,
,
.

(, . SSRI)


. .
,

.
(, , , , , ,
), (, , , , ),
(, , , ),
(, ), (, , ),
(, , , ).
C
: , ( ),
(
, , , ),
, , ,

29

 , ( ),
, , (), ,
, ()
, , .

(C, . NARI)


.

.
(),
(). ,
,
. ,


(), .

(C, . SNRI)

, (doubleaction antidepressants),

.
,

,
().
.
(), ,
().

(, . SDRI)

30

(,
).

, , ,
.

,
.

,
,

.

( ,
, ,
),
,
.

, .

(, . NaSSA)


.
, ,
-2
,

5-HT2 5-HT3 ,

. ,
5-HT2 ,
,
, , .

31

 5-HT3
, .

5-HT2 5-HT3


5-HT1,
, , ,
. ,

(
).

(, )
().

(, . SSA)

.


5-HT2,
(
, , ),
,
. , ,
,
,
.
()
().

.
.
, ,

32

 REM-,
.
,
.

(
),
.

III
()

:

( ,
?)

, ,

.
,

);

.
.

, ,
, ,
.

23 .

. ,
( - ) ,

33


. ,
6
(. . , 1995; . . ,
2006). ,

( 4- ), 2-
.
,

,
.
( 6 )

(
),
. (. .
, 2005) ,
34
,
( ).

24 (. .
Thase, 1987).
1.
,
, 46 ,

1012 .

, ,
1016 (. Frank, 1990).


.
, (. . ,
2000),
,
24 . (.

34

. , 2002),
, 200 200300
.
,
.
,

.
. ,
,
,
.
, ,
.
( 40
). ,
300
(!) (. , 2004).
,

2).
,
( ,
,
,
,
).
,
2 .
,

,
,

( ).

,
.
:

35

 ,
.
2.


( . . 2005, )

, , ,
, , , ,
,
, ,
, , ,

, , ,
, , ,
, , ,
, , ,
, ,
, ,
,
, , ,
, , ,

, ,
, ,
, , ,
, ,
, , ,
,
, , ,
, ,
, ,
,
,

(

)
16-46 (24)

12-51 (18)

10-47 (17)
12-34 (22)

17-28 (24)
18-88 (26)

8-30 (12)
20-58 (43)
17-48 (32)
3-15 (24)
10-109 (24)
15-22 (20)
60-360 (168)
33
1-2 (1)

3 ,
.

36

 ,
,
,

/ , , ,
.
3.
,

( . . , 2003)

25100
125200
25100 /
125200 /
+ / 2550
+ / 75100

225400
225400 /
+ / 125150

2550 /
+ / 2550

75100 /
+ / 75100

5075 /
+ / 5075

2575 /
100250 /
250400 /
+ / 2550
+ / 75100
+ / 125150

12,525
37,5
50

25125 /
150250 /
275400 /
+ / 2550
+ / 75125
+ / 150200

2575 / + 100175 / + / 50
200250 / + / 100
/ 25
75

1530
30-90
120

75150
225450
525600

10
20
4080

50
50100
150200

50
100200
250400

20
20
4080

20
40
4060

5075 / + /
100400 / + /
450800 / + /

150
150300
300-600

37

2575 /
+ / 2550

100225 /
+ / 75100

250500 /
+ / 125200

 ,

.
,
400 - 0,9%- -
5%- -
1,52 .
1070 . . . (1995),
,
.

,
,

,
(
).
, , ,
.
, .. ,

.

,
,

. :

? ,

.
,
,
50%
(. . , 2004; P. J Cowen, 1998).

38

 ,
(
,

). ,

? .

(. .
, 2005),
(, ,
) ( 2). ,
(. . , 1998)
, , 1/3

. ,
,
, , ,
. (. . , 2005; . . Thase,
1995; . . Nemeroff, 1996),
30 50% (,
). , ,
,
,

.

.
,

, ,
(, ),
.

, ,
, .


(. . Guze, 1987;

39

J. D Amsterdam, 1989).
.

?
,
. ,
() ,

, (,
),
.
,

. P. J.
Cowen (1998)


.

,

.
,
2030% (P. J Cowen, 2005).


. (
) .


.

,
,
. . . (2005),

(

40

 2). ,


(. . , 2002).

60-
. ,
,

. ,

+,
. ,

,
, (. . , 2000)
- . ,
,
2-3 ,

, :
- ( !);
- ;
- ,
;
- +
(
);
- ( ),
.


. ,
(J.
B Weilburg, 1989; . Fava, 1995). ,

, ,
, ,

41

450, . + ,
,
( 50 /
).


,

,
-
,

,
,
(. . , 2000).


.

. ,
.
,
,
.



.
.


(. . , 1989).
()
( )
.
()

,
. (. . ,
1988; . . , 1995),


. ,
1014 ,

42


( ).
( ,

).

510 .

.
,
,
.

()

.

, , ,
(. . 1993).
,
,
-
( )
. ,

.

:
+
()

70-
,
,
.
(
augmentation , ). ,

,
.
,

43

1.
,
.
,
. ,
,
.

,
.

,
, 3065 %
26 (. Fava, 1995; .
Bauer, 2003).

.
,

(. Bauer, 1999) ,

.

48 (. de Montigny, 1994).
(. , 2004),
, +
.
,

, , ,
0,50,8 /.
. , P. J. Cowen (1998)
, , 200400
,
, ,
200 . . (2004)
: 300

44

 23 .
,
,
, .
+ (
)
L.
, , .
2.

,
.
( 2040% )
(D. Kahn, 1990; .
Cullen, 1991). 4002000 /,
34 .

70- ,

.
,

. ,

,

. ,

(. . , 2008).
,
(T3),
, (T4) (R. T Joffe,
1990). , T3
2040 / ,
5060 % (R. T Joffe, 1996; P. J. Cowen,
1998). (. . Thase, 1995), T3

45

,
( ). (P. J.Cowen,
1998), , 3
,
, ,
, 3
.
L
L
.
, 47 /,
34 . (1
4 /),
(. . , 1995).
, L-
(P. J Cowen, 1998). ,
L-
+
+ ( ).
(L )

70-
. ,

. ,

(. . ,
1995).

().

(,
) (L-,
)
.

.
L

, 3,54 /,

46

 .
, ,
.

: (), (),
(), (),
(), (). ,

2030% (. . Robertson, 1982),
,
, .
,

. ,
.

.

,
(. . , 2007;
2008). ,


.


.
,
(P. J. Cowen 1998; 2005).
,
, , ,
.

, ,

47

 (. , 2004). ,
(, )
,
(. . , 2002).

,
, (J. Fawcett, 1991; R. Fontaine,
1991)
.


( . . , . . , 2007)
,

,
.
. . .
,

.

,

.


,
,
,
.
( 4- )
.

48

 1.

-10

-10.
,
, ,
.


: ,
.
,

.

49

 ,
,

. ,
,

.
:
()
:
( )
()
174
.
: 2060
/, 50150 /, 100200 /,
50200 /. :
50300 /, 2,530
/, 16 /, 100300 /.
,


.


.

(, )
,

).

.

(),

( ).

4-

50 %
.

50

 ,
, .
,
1020%.


.

, , ,
( ,
),
.
, (
), . ,
,
, (
)
. ,


, , ,
,
, (
3).

1.

()

. , ,
.
,

.
( . .
, 2005).

51

 ,
.


,
,
. ,
, . ,

(, ),
,
.
,
-
.

. ,
.

.

-01,
,
( ).

,

.

.
,
. ,
1
,

. , , ,
(P. J. Cowen, 2005),
:

52

 ,
. ,
.
( 2), ,

- ,
. ,
2 4 -

(. . , 2005).
,
, :
,
.
,
5080 % (.
. , 2006; P. J. Cowen, 2005).

, ,
27% (. . , 2005).
()


,
() () ,
.

(. . , 2005).

,
.
,
3 ; 1525 .
75 125 .
12,525 ,
(275300 ).
, ,

53


. ,

, .
. . (2000)
-
.
,
,
,
. , ,
(
,
),
, /
,

,
.
()

()

,
() .

, , .
(
)
.
65% (. .
, 1998).
. ,
,

.

.

,

54


.

.
:
,

.
800 1600 , 13 .

.
, 1200
,

(520% , ).

( . . , 1997):
- ;
- ;
- ;
- ;
- - ;
- - ;
- .
(
70%) , :
, , . 50 % ,
. 50 %
. ,
, ,
,

.
.


.
()

55

 ()

/
-. ,

, .
(
),

( ).
,

. ,

,
,

.
()

- .

,
- - .
-
,
. ,

, ,
.
(
) 60% (. . , 1998).
,
,
,
. ,
(. . , 1994). ,

56


.

- -1 (. .
, 2006). 0,63 ,
8 .
15 , 8
12 .
.
()

. 1966 . W. Schulte
. ,
8399%
.

. ,
(
REM-).
(. . ,
2006): , .
3640 .
. 17 24 ,
21 1 30
, .
,
5 . ,
.
.
, ,
.
,
, ,
.
,
,
. ,
, :
.

57

,
,
,
,
.

, .
,


(. . , 2006).

.

, ,
.

2.

,
( ),

(), (),
() ().
,
,

58

, ,
, .


.
()
1985 .,
,

.
,
.
100 200 ,
, ,
,
.
,
(M. S. George,
2003).

, .
.
(M. S. George et al., 1995; . Conc et al., 1996),

,
.

, .

(. . , 2008)
,
. (. . ,
2005),
60 %.
,
- .

59


, ,
. . .
(2006),
10 , 30 .
, 1,6\1.

.


.
- ()
,

. 40%
,
0,4 (
). ,

.

,
.
(S. H., Lisanby, 2001; T. D. Moscrip, 2005),
.
()

, 1994 .
,
, .

,
(M.
S. George et al., 2003). ,

, ,
( ).

60

,
(. . , 2006).
.
( )

,
.
5 .


. ,
(
, ).
, ,
10
(
),
. , 60 ,
30% 50%-
10
. ,
: ,
46%
.
()
,
.

.
(. . ,
2005). ,

. ,
.

, ,
.
( 1 )

61

,
.
: , ,
.


.

(. .
Kopell, 2004).
()


( , ,
).
().

. ,

,

. ,

. 80- ,
,

, .

.

.
,
(
).
,
, ( )
.

62

, (
- ) (. .
, 2006).

.
, 2,5
, 30 200 .
(. . , 2000)
45 ,

. 60 ;
60 , 35004000 lux.
15,
,

.

,
.
,
, , .

( )

,
, :
1. ,
- .

.
2.
( ,
)
,
.
3. ,
, ,
,
.

63

4.
.
5.
,

.
6. ,
,
, ,
,
.
7. ,

64


1

(Hirschfeld et al., 2002)

(, )

65

 2
()
. . 1995,

1


(, , )
, :

, ,
2-

2
: - (,
, ) - (, ,
) - (, )
, :

,
. ,
, 3

3-
*: -
+
- ( + ) - + + - ** +

:
-
-
:
***
-
- L
-
- L -
-
-
-

-
-
-
-
-
-
- -

, :

66

4
(, )
(
)
, :

5
-
- (. 3 )
- (. 3 )
*-
** - 2-
*** -

P. J. Cowen 1998
)
(
);
) (, ,
);
) ;
) ;
) ( );
) (, + , +
+ L-, + + L-).


.

67


1. . ., . . :
. 2- ., . . .: ,
1988. - 528 .
2. . .
( ). .:

. - , 1975. - .7588.
3. ., .
/ . . - .: , 2004. -416 .
4. . . ( ).
: -. , 2002. - 336 .
5. . . . :
-. , 2005. - 576 .
6. . . .
. . . 2009, 1(109).
. 9091.
7. . .
(, , ). .
... . . . .: 1992.
8. . .

. XIII ( ). .:
, 2000. - . 153154.
9. . ., . . :
( ).

http://www.psychoreanimatology.org 15.05.2005 .
10. . ., . .
( , , ).
. - 2005; 4(15). .1823.
11. . . -
.
.: . .: 1975. - .
513.
12. . ., . . .
.: , 1982. - 192 .

68

13. . ., . ., . .
(

).

. .: , 1989. - . 151
181.
14. . .
.
. . . . 1998, 10(98). . 63 67.
15. . ., . .

( ). .: - . .
, 2007. - 28 .
16. . ., . ., . .

,
.
. 2008, 2. - . 7380.
17. . . .
. 2002, 12-13(10). . 553555.
18. . ., . . :

-
.
. 2006, 2(16). - . 93100.
19. . . :
. . -2004, 4(14). . 59
65.
20. . ., . ., . .
:
. - . - 2008; .
2, 11.- .8796.
21. . . . ., 1997.
- 143 .
22. . . . .:
, 2000 - 208 .
23. . .
.
. 2003, 1(5). . 3840.
24. . ., . ., . . .

69

 - .
. .: , 1998. - . 229232.
25. . . . .: -, 2006. - 320 .
26. . .
. . 2003, 3(9). . 22
27.
27. . .
.
. . . . 2000, 12(100). . 6872.
28. . .
. .: ,
1995. - 568 .
29. . .
. . 2005, 12(13). .
852 -857.
30. . .
. . 2004, 2.
.128-132.
31. . ., . ., . . .

. .
1995, 4(3). - . 7681.
32. . . 1999 . -

. . ... . . . ., 1999.
33. . . ,
. .; . , 2005. 368 .
34. . ., . . .
. 2002, 1. - . 118
124.
35. . ., . ., . . .


. .
2006, 2(16). . 4751.

70

36. . .
. . .
. . . ., 2005.
37. . .
. .: , 2007. 432 .
38. . . :
. .
2006, 3(8). - . 410.
39. . . .
. 2000, 1. - . 1820.
40. . ., . ., . ., . .

(
). . .
. 1990, 10(90). - .71-73.
41. . ., . ., . .

.
.. 1994, 1. .118-120.
42. . ., . ., . .
/ . . : -, 1999. - 694
.
43. . .

. . . . . . ., 1993.
44. Amsterdam J. D., Berwish N. J. High dose tranylcypromine therapy for
resistant depression. Pharmacopsychiatry. 1989, 22. . 2125.
45. Ballas C., Staab J. P, Evans D. L. Strategies for treatment-resistant
depression. Psychopharmacol Bull. 2002, 36(4). . 39-62.
46. Bauer M., Adli M., Baethge C. et al. Lithium augmentation therapy in
refractory depression: clinical evidence and neurobiological mechanisms.
Can J Psychiatry. 2003, 48(7). . 440-448.
47. Bauer M., Dpfmer, S. Lithium augmentation in treatment-resistant
depression: meta-analysis of placebo-controlled studies. Journal of Clinical
Psychopharmacology. 1999, 19. . 427434.
48. Conca A., Koppi S., Konig P. et al. Transcranial magnetic stimulation:
a novel antidepressive strategy? Neuropsychobiology. 1996, 34. - . 204207.

71

49. Cowen P. J. Pharmacological management of treatment-resistant

depression. Advances in Psychiatric Treatment. 1998, 4. . 320327.
50. Cowen P. J. New drugs, old problems. Advances in Psychiatric
Treatment. 2005, 11. . 1927.
51. Cross-national comparisons of the prevalences and correlates of mental
disorders. Bull. WHO. 2000, 78. . 413426.
52. Cullen M., Mitchell P., Brodaty H. et al. Carbamazepine for treatmentresistant melancholia. J Clin Psychiatry. 1991, 52. . 472476.
53. de Montigny C. Lithium addition in treatment-resistant depression. Int
Clin Psychopharmacol. 1994, 9 (Suppl 2). . 31-35.
54. Fava M., Rappe S. M., Pava J. A. et al. Relapse in patients on longterm fluoxetine treatment. J Clin Psychiatry. 1995, 56. . 52-55.
55. Fawcett J., Kravitz H. M., Zajecka J. M., Schaff M. R. CNS stimulant
potentiation of monoamine oxidase inhibitors in treatmentrefractory
depression. J Clin Psychopharmacology. 1991, 11. . 127132.
56. Fontaine R., Ontiveros A., Elie R., Vzina M. Lithium carbonate
augmentation of desipramine and fluoxetine in refractory depression. Biol
Psychiatry. 1991, 29. . 946948.
57. Frank E., Kupfer D. J. Axis II personality disorders and personality
features in treatment-resistant and refractory depression. In: Roose S. P.,
Glassman A. H., eds. Treatment strategies for refractory depression.
Washington, DC: American Psychiatric Press; 1990. - . 205221.
58. George M. S., Wassermann E. M., Williams W. A. et al. Daily
repetitive transcranial magnetic stimulation (rTMS) improves mood in
depression. Neuroreport. 1995, 6. . 1853-1856.
59. George M. S., Rush A. J., Sackeim H. A., Marangell L. B. Vagus nerve
stimulation (VNS): utility in neuropsychiatric disorders. Int. J.
Neuropsychoparmacol. 2003, 6. . 73-83.
60. Guze B. H., Baxter L. R., Rego J. Refractory depression treated with
high doses of a monoamine oxidase inhibitor. J Clin Psychiatry. 1987, 48.
. 3132.
61. Hirschfeld R. M., Montgomery S. A., Aguglia E. et al. Partial response
and nonresponse to antidepressant therapy: current approaches and
treatment options. J Clirt. Psychiatry. 2002, 63. . 826-837.
62. Joffe R. T., Levitt A. J. Antidepressant failure: augmentation or
substitution? J Psychiatry Neurosci. 1995, 20. . 7-9.
63. Joffe R. T., Levitt A. J., Sokolov S. T. Augmentation strategies. J Clin
Psychiatry. 1996, 57 (Suppl 7). . 25-31.

72

64. Joffe R. T., Singer W. A comparison of triiodothryonine and thyroxine

in the potentiation of tricyclic antidepressants. Psychiatry Res. 1990, 32.
. 241-245.
65. Kahn D. Carbamazepine and other antiepileptic drugs in refractory
depression. In: Roose S. P., Glassman A. H., eds. Treatment strategies for
refractory depression. Washington, DC: American Psychiatric Press; 1990.
. 75107.
66. Keller M. B. Course outcome and impact on the community. Acta
Psychiat. Scand. 1994, 89. . 2434.
67. Kopell B. H., Greenberg B., Rezai A. R. Deep brain stimulation for
psychiatric disorders. J Clin. Neurophysiol. 2004, 21. .51-67.
68. Lisanby S. H., Morales O., Payne N. et al. New developments in
electroconvulsive therapy and magnetic seizure therapy. CNS. 2003,
Spectr. 8. - . 529-536.
69. Lisanby S. H., Schlaepfer . ., Fisch H. U., Sackeim H. A. Magnetic
seizure therapy of major depression. Arch. Gen. Psychiatry. 2001, 58.
. 303-305.
70. Moscrip T. D., Terrace H. S., Sackeim H. A., Lisanby S. H.
Randomized controlled trial of the cognitive side-effects of magnetic
seizure therapy (MST) and electroconvulsive shock (ECS). Int. J
Neuropsychopharmacol. 2005, 1. . 1-11.
71. Nemeroff C. B. Augmentation strategies in patients with refractory
depression. Depress Anxiety. - 1996-97, 4. - 169-181.
72. Nierenberg A. A., White K. What next? A review of pharmacologic
strategies for treatment resistant depression. Psychopharm Bull. 1990, 26.
. 429460.
73. Russell J. M., Hawkins K., Ozminkowski R. J. et al. The cost
consequences of treatment-resistant depression. J Clin Psychiatry. 2004,
65(3). . 341-347.
74. Thase M. E., Kupfer D. J. Characteristics of treatment-resistant
depression. In: Zohar J., Belmaker R. H., eds. Treating resistant depression.
New York: PMA Publishing, 1987. - . 2345.
75. Thase M. E., Rush A. J. When at first you dont succeed, sequential
strategies for antidepressants non-responders. Journal of Clinical
Psychiatry. 1997, 58. - . 2329.
76. Thase M. E., Rush J. A. Treatment-resistant depression. In: Bloom F.
E., Kupfer D. J., eds. Psychopharmacology. New York: Raven, 1995. .
1081-1097.

73

77. Trivedi M. H. Treatment-resistant depression: new therapies on the

horizon. Ann Clin Psychiatry. 2003, 15(1). . 59-70.
78. Weilburg, J. B., Rosenbaum, J. F., Biderman, J., et al. Fluoxetine added
to non-MAOI antidepressants converts non-responders to responders: a
preliminary report. Journal of Clinical Psychiatry. 1989, 50. . 447-449.

12.10.2009 .
6084 1/16

. . . 5,23
. .. 5,12
211
500 .
+

. ., 2009

74